Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
CHP1 pseudogene 3 (CHP1P3) is a processed pseudogene derived from the calcineurin like EF-hand protein 1 (CHP1) gene. Pseudogenes are genomic DNA sequences similar to normal genes but are non-functional, usually due to mutations or lack of regulatory elements required for expression or translation[3][4][5]. Unlike its parental gene CHP1, which codes for a regulatory protein involved in ion transport and pH regulation, CHP1P3 does not code for a functional protein and has no reported physiological or pathological role. Pseudogenes in general can occasionally act at the RNA level, for example by acting as competing endogenous RNAs (ceRNAs) or miRNA sponges, but there is currently no curated evidence that CHP1P3 is transcriptionally active or has a biological role. It is not considered a receptor, enzyme, drug target, or biomarker by major genomic and pharmacological databases as of this date[3][5][4].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on CHP1 pseudogene 3 (CHP1P3).